All Stories

  1. Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye? Diabetes Care 2021;44:641–646

    Article • Diabetes Care, June 2021, American Diabetes Association

    Giulia Ferrannini

  2. Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye?

    Article • Diabetes Care, February 2021, American Diabetes Association

    Giulia Ferrannini

  3. Erratum. Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study. Diabetes Care 2020;43:843–851

    Article • Diabetes Care, January 2021, American Diabetes Association

    Giulia Ferrannini

  4. A Journey in Diabetes: From Clinical Physiology to Novel Therapeutics: The 2020 Banting Medal for Scientific Achievement Lecture

    Article • Diabetes, January 2021, American Diabetes Association

    Giulia Ferrannini

  5. Is Coronary Artery Disease Inevitable in Type 2 Diabetes? From a Glucocentric to a Holistic View on Patient Management

    Article • Diabetes Care, July 2020, American Diabetes Association

    Giulia Ferrannini

  6. Mechanisms of Sodium–Glucose Cotransporter 2 Inhibition: Insights From Large-Scale Proteomics

    Article • Diabetes Care, June 2020, American Diabetes Association

    Giulia Ferrannini

  7. Coronary patients and diabetes in Europe

    Article • Diabetes Care, February 2020, American Diabetes Association

    Giulia Ferrannini, Professor Erkin Mirrakhimov

  8. Proteomic study in type 2 diabetes and coronary artery disease

    Article • Diabetes Care, January 2020, American Diabetes Association

    Giulia Ferrannini

  9. Risk factor reduction in type 2 diabetes demands a multifactorial approach

    Article • European Journal of Preventive Cardiology, November 2019, SAGE Publications

    Giulia Ferrannini

  10. Renal Handling of Ketones in Response to Sodium–Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes

    Article • Diabetes Care, March 2017, American Diabetes Association

    Giulia Ferrannini

  11. Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes

    Article • European Heart Journal, June 2015, European Society of Cardiology

    Giulia Ferrannini